Safeguarding Women from Chemical Abortion Act
Sponsored By: Representative Harshbarger, Diana [R-TN-1]
Introduced
Summary
Withdraws federal approval of mifepristone for termination of intrauterine pregnancy and establishes a new federal tort allowing lawsuits against its manufacturers. This bill would deem FDA approvals for mifepristone (marketed as Mifeprex, also known as RU‑486) withdrawn 14 days after enactment and would create a private cause of action tied to that drug.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Right to sue mifepristone makers
This bill would let any person who suffered bodily injury or mental-health harm tied to using mifepristone sue the drug maker. You could bring the case in a federal or State court. You could seek compensatory damages, punitive damages, and attorney fees and costs. This would take effect 90 days after enactment and would not stop State laws that give other remedies.
Withdraws FDA approval for mifepristone
This bill would treat FDA approval for mifepristone to end pregnancy as withdrawn 14 days after enactment. Making, importing, delivering, or selling the drug for that use would be a federal violation. Labels saying the drug may be used to end intrauterine pregnancy or with another drug for that purpose would be considered misbranding. If enacted, this could reduce nationwide access and raise legal and compliance risks for manufacturers, pharmacies, clinicians, and patients.
Sponsors & CoSponsors
Sponsor
Harshbarger, Diana [R-TN-1]
TN • R
Cosponsors
Rose
TN • R
Sponsored 3/18/2026
Rep. Dunn, Neal P. [R-FL-2]
FL • R
Sponsored 3/20/2026
Rep. Alford, Mark [R-MO-4]
MO • R
Sponsored 3/20/2026
Biggs (SC)
SC • R
Sponsored 3/24/2026
Rep. Mann, Tracey [R-KS-1]
KS • R
Sponsored 3/24/2026
Rep. Smith, Christopher H. [R-NJ-4]
NJ • R
Sponsored 4/22/2026
Rep. Miller, Mary E. [R-IL-15]
IL • R
Sponsored 5/14/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov